← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Emtricitabine, Tenofovir disoproxil currently has availability issues reported in 3 European registers: Ireland, Italy, Sweden.
Shortage ATC — · also listed as: Emtricitabine, Tenofovir disoproxil · EMTRICITABINA + TENOFOVIR DISOPROXIL · emtricitabin, tenofovirdisoproxilmaleat · emtricitabin, tenofovirdisoproxil · data refreshed 12 September 2026
As of 12 September 2026, 3 of the 9 tracked registers list current availability issues for Emtricitabine, Tenofovir disoproxil, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2024-10-01 and has now been open for about 23 months. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-01; the earliest is 2026-10-07. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Italy reported first (2024-10-01), with Ireland following roughly 22 months later — a pattern typical of supply problems cascading between national markets. Registers in Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇪 Ireland | Shortage Emtricitabine / Tenofovir disoproxil Accordpharma 200 mg / 245 mg film-c | 2026-08-05 | 2026-10-07 | Manufacturing delay (Ireland only) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇮🇹 Italy | Shortage EMTRICITABINA E TENOFOVIR DISOPROXIL TEVA + 1 more productsEMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN | 2024-10-01 | 2026-11-30 | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Emtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg Filmdragerad tablett + 1 more productsEmtricitabine/Tenofovir disoproxil Sandoz 200 mg/245 mg Filmdragerad tablett | 2026-04-30 | 2026-12-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Emtricitabine, Tenofovir disoproxil in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇪 IE | Emtricitabine / Tenofovir disoproxil Accordpharma 200 mg / 245 mg film | Shortage | 2026-08-05 | 2026-10-07 | Manufacturing delay (Ireland only) |
| 🇸🇪 SE | Emtricitabine/Tenofovir disoproxil Sandoz 200 mg/245 mg Filmdragerad t | Shortage | 2026-05-11 | 2026-08-21 | |
| 🇸🇪 SE | Emtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg Filmdragerad ta | Shortage | 2026-04-30 | 2026-12-01 | |
| 🇮🇹 IT | EMTRICITABINA E TENOFOVIR DISOPROXIL TEVA | Shortage | 2026-04-15 | 2026-11-30 | Problemi produttivi |
| 🇮🇹 IT | EMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN | Shortage | 2024-10-01 | — | Problemi produttivi |
Yes. As of 12 September 2026, availability issues are reported in: Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-07 to 2026-12-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Emtricitabine, Tenofovir disoproxil: HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Emtricitabine, Tenofovir disoproxil — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/emtricitabine-tenofovir-disoproxil/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Emtricitabine, Tenofovir disoproxil availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/emtricitabine-tenofovir-disoproxil/">Emtricitabine, Tenofovir disoproxil shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>